BLUEMED

BLUEMED is the research and innovation initiative for promoting the blue economy in the Mediterranean Basin through cooperation between all Mediterranean countries for a healthy, safe and productive Mediterranean Sea.

The BLUEMED project is a Coordination and Support Action funded by the Horizon 2020 Programme aimed at supporting the implementation of the BLUEMED initiative as a key policy reference for all actors of the Blue Growth in the Mediterranean. The project aims also to promote and implement the BLUEMED Strategic Research and Innovation Agenda (SRIA) by converting its outputs into actions.

The project aims also to promote and implement the BLUEMED Strategic Research and Innovation Agenda (SRIA) by converting its outputs into actions. The project is coordinated by the National Research Council (CNR) and is composed of 11 beneficiaries from 9 different countries. Malta is represented in the project by the Malta Council for Science and Technology and is responsible for a number of tasks including the coordination of Work Package dealing with the Start-up Actions. MCST also represents Malta at the meetings of the Group of Senior Officials Working Group, an overarching body tasked with the promotion and extension of the BLUEMED Initiative to non-EU countries.

Europe Enterprise Network (EEN) – MELIITA 3

Enterprise Europe Network (EEN) is the largest support network for small and medium-sized enterprises (SMEs) which helps them innovate and grow on an international scale. The network is active in more than 60 countries worldwide. In Malta, 4 local organisations – Malta Enterprise, the Malta Business Bureau, the Malta Chamber of Commerce and the Malta Council for Science and Technology – have come together and pooled their resources to offer a more consolidated and value-added service to the local business community.

The Malta EEN Network is also supported by the MELIITA project (funded through Horizon 2020 and COSME) and aims to support the smart growth of the Maltese SMEs by increasing the efficiency and effectiveness of investments in research, development and innovation. The current project, MELIITA 3 started in January 2019 and will run up to 2020.